Skip to main content
Log in

Anticardiolipin antibodies are no marker for survived myocardial infarction

  • Originals
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

Antiphospholipid antibodies — both the lupus anticoagulant and anticardiolipin antibodies — are closely associated with arterial and venous thrombosis. In this prospective trial the IgM- and IgG-anticardiolipin antibodies in serum were determined in acute and chronic coronary artery disease. Seventy-four unselected males (34–87 years, mean 60) were included in the study. All patients underwent coronary angiography; infectious and autoimmune diseases were exclusion criteria. Sixteen patients had coronary artery disease (group A), 34 showed coronary stenoses with prior infarction (B), and 14 had survived an acute myocardial infarction (C), whereas 10 patients revealed no significant coronary narrowing (D; controls). The major risk factors were the same for all groups. Neither the IgM- nor the IgG-anticardiolipin antibody levels showed any significant difference in the four groups. The severity of coronary artery disease did not correlate to these antibodies. Furthermore, no correlation was found between elevated anticardiolipin antibodies and thrombocyte levels. Thus, a higher anticardiolipin level does not appear to be a marker for recurrent cardiovascular events.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ACA:

anticardiolipin antibodies

CAD:

coronary artery disease

MPL-U/ml:

IgM phospholipid-units/ml

GPL-U/ml:

IgG phospholipid-units/ml

References

  1. Careras LO, Machin SJ, Deman R, Defreyn G, Vermylen J, Spitz B, Van Assche A (1981) Arterial thrombosis, intrauterine death and ‘lupus’ anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet 8145:244–246

    Google Scholar 

  2. Cowchock S, Fort J, Munoz S, Norberg R, Maddrey W (1988) False positive ELISA tests for anticardiolipin antibodies in sera from patients with repeated abortion, rheumatologic disorders and primary biliary cirrhosis: correlation with elevated polyclonal IgM and implications for patients with repeated abortion. Clin Exp Immunol 73:289–294

    Google Scholar 

  3. Eber B, Biondi ML, Auch-Schwelk W, Vanhoutte PM (1989) IgM-anticardiolipin antobidies evoke endothelium-independent relaxations in isolated canine coronary arteries. The Physiologist (abstract) 32:189

    Google Scholar 

  4. Feinstein DI (1985) Lupus anticoagulant, thrombosis, and fetal loss. N Engl J Med 313:1348–1350

    Google Scholar 

  5. Hamsten A, Norberg R, Björkholm M, DeFaire U, Holm G (1986) Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet 8473:113–115

    Google Scholar 

  6. Harris EN, Gharavi AE, Asherson RA, Boey ML, Hughes GRV (1984) Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol 2:47–51

    Google Scholar 

  7. Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S, Hughes GRV (1983) Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematodes. Lancet 8361:1211–1214

    Google Scholar 

  8. Hughes GRV, Harris NN, Gharavi AE (1986) The anticardiolipin syndrome. J Rheumatol 13:486–489

    Google Scholar 

  9. Kushner M, Simonian N (1989) Lupus anticoagulants, anticardiolipin antibodies, and cerebral ischemia. Stroke 20:225–229

    Google Scholar 

  10. Moore JE, Mohr CF (1952) Biologically false positive serologic tests for syphilis. J Am Med Ass 150:467–473

    Google Scholar 

  11. Morton KE, Gavaghan TP, Krilis SA, Daggard GE, Baron DW, Hickie JB, Chesterman CN (1986) Coronary artery bypass graft failure — an autoimmune phenomenon? Lancet 8475:1353–1356

    Google Scholar 

  12. Lockshin MD, Druzin ML, Goei S, Quamar T, Magid MS, Jovanovic L, Ferenc M (1985) Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 313:152–156

    Google Scholar 

  13. Norberg R, Ernerudh J, Hamsten A, Unander AM, Arfors L (1987) Phospholipid antibodies in cardiovascular disease. Acta Med Scand 715:93–98

    Google Scholar 

  14. Vismara A, Meroni PL, Tincani A, Harris EN, Barcellini W, Brucato A, Khamashta M, Hughes GRV, Zanussi C, Balestrieri G (1988) Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematodes. Clin Exp Immunol 74:247–253

    Google Scholar 

  15. Weidmann CE, Wallace DJ, Peter JB, Knight PJ, Bear MB, Klinenberg JR (1988) Studies of IgG, IgM and IgA anti-phospholipid antibody isotypes in systemic lupus erythematosus. J Rheumatol 15:74–79

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eber, B., Kronberger-Schaffer, E., Brussee, H. et al. Anticardiolipin antibodies are no marker for survived myocardial infarction. Klin Wochenschr 68, 594–596 (1990). https://doi.org/10.1007/BF01660956

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01660956

Key words

Navigation